Education
About Us
Working with TipRanks
Follow Us
Brad's Biorunup - New Portfolio
Lazy Brad
Brad's BiorunupIndividual Investor
Ranked #205,174 out of 833,817 TipRanks' Investors
Success Rate
31 out of 46
profitable transactions
profitable transactions
Average Return
22.59%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▲ 17.68%
6-Month Return▲ 34.41%
12-Month Return-
YTD Return▲ 72.66%
Total Return▲ 72.66%
Best Trade
Bio
As a serious and responsible investor, I secured my assets in a classic Lazy Portfolio, the old good 60/40.
Can you imagine how boring it is? So the Mr. Hyde in me diverted some pocket $$ from it to cherry-pick this bunch of risky, volatile stocks.
Performance
32.43%0-32.43%
▲ 11.63%
▲ 6.28%
▲ 32.43%
May 2025
▲ 9.25%
▲ 5.14%
▼ 2.25%
Jun 2025
▲ 7.60%
▲ 2.30%
▼ 3.64%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 1.90%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 8.95%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 4.48%
Oct 2025
▼ 3.57%
▲ 0.19%
▲ 4.88%
Nov 2025
▲ 1.45%
▲ 1.32%
▲ 16.45%
Dec 2025
▲ 11.63%▲ 6.28%▲ 32.43%
▲ 9.25%▲ 5.14%▼ 2.25%
▲ 7.60%▲ 2.30%▼ 3.64%
▲ 2.76%▲ 2.05%▲ 1.90%
▲ 12.88%▲ 3.56%▲ 8.95%
▲ 10.96%▲ 2.38%▲ 4.48%
▼ 3.57%▲ 0.19%▲ 4.88%
▲ 1.45%▲ 1.32%▲ 16.45%
Recent Activity
89bio
―
▲ 34.79%
3
Close
Oct 29, 2025
ProKidney
0%
▼ 21.88%
1
Open
Oct 19, 2025
Syndax Pharmaceuticals
0%
▲ 38.73%
1
Open
Oct 19, 2025
Kura Oncology
0%
▲ 34.06%
1
Open
Sep 19, 2025
Vanda
0%
▲ 53.90%
1
Open
Sep 19, 2025
Exelixis
0%
▲ 15.99%
1
Open
Sep 19, 2025
Intuitive Surgical
0%
▼ 2.11%
2
Sell
Sep 18, 2025
DoorDash
―
▲ 40.83%
3
Close
Sep 18, 2025
Biomea Fusion
0%
▼ 37.98%
1
Open
Sep 18, 2025
Fortress Biotech
0%
▲ 3.09%
1
Open
Sep 18, 2025
Arcutis Biotherapeutics
0%
▲ 66.29%
1
Open
Sep 18, 2025
Cidara Therapeutics
0%
▲ 210.11%
1
Open
Sep 18, 2025
Apogee Therapeutics
0%
▲ 103.20%
1
Open
Sep 18, 2025
Celldex
0%
▲ 3.51%
1
Open
Sep 18, 2025
Aclaris Therapeutics
0%
▲ 55.90%
1
Open
Sep 18, 2025
Adagio Medical Holdings
0%
▼ 41.76%
1
Open
Sep 18, 2025
Imunon
―
▲ 12.37%
2
Close
Jun 19, 2025
Doximity
―
▼ 1.21%
2
Close
Jun 19, 2025
Urogen Pharma
―
▲ 71.37%
2
Close
Jun 13, 2025
Protagonist Therapeutics
―
▲ 1.24%
2
Close
Jun 13, 2025